Eton Pharmaceuticals Inc. Revenue 2019–2025
Eton Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Eton Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 24.3 M, a 40.41% increase year-over-year.
- Eton Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 82.9 M, a 141.15% increase year-over-year.
- Eton Pharmaceuticals Inc. annual revenue for 2025 was 80.0 M, a 104.94% increase from 2024.
- Eton Pharmaceuticals Inc. annual revenue for 2024 was 39.0 M, a 23.29% increase from 2023.
- Eton Pharmaceuticals Inc. annual revenue for 2023 was 31.6 M, a 48.90% increase from 2022.
- Eton Pharmaceuticals Inc. annual revenue for 2022 was 21.3 M.
Eton Pharmaceuticals Inc. (ETON) — Frequently Asked Questions
Eton Pharmaceuticals Inc. (ETON) is a publicly traded US company. It has a market capitalization of $837M. In fiscal 2025 it reported revenue of $80M and net income of -$5M. Explore ETON's stock price, financial statements, earnings history, margins and key ratios below.
What is Eton Pharmaceuticals Inc.'s market cap?
Eton Pharmaceuticals Inc. (ETON) has a market capitalization of $837M.
What is the ETON stock price?
ETON trades at $30.95 (+1.38% on the day).
How much revenue does Eton Pharmaceuticals Inc. make?
Eton Pharmaceuticals Inc. reported revenue of $80M in fiscal 2025.
Is ETON profitable?
In fiscal 2025, Eton Pharmaceuticals Inc. reported net income of -$5M.